Retail healthcare giant Clicks on Wednesday noted in a voluntary trading update that pharmacy sales in South Africa “have been negatively impacted as the country has not experienced a traditional winter cold and flu season”.
The group did not mention the extent of the impact, however, it highlighted that colds and flu are generally strong drivers of sales growth for the company.
“The incidence of colds and flu has been limited as South Africans are wearing face masks during the pandemic, social interaction has been limited, schooling restricted and large numbers of people are working from home,” it pointed out.
Despite the knock to pharmacy sales, Clicks reported that total retail sales grew by 6.3% for the 23-week period from 1 March to 9 August this year.
The relatively strong performance in the face of Covid-19, saw its share price rise more than 5% (to around R241) in midday trade on Wednesday.
This article first appeared on Moneyweb and was republished with permission.